Bio-Rad Laboratories Inc - Class A
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.
Earnings per share grew at a -13.1% CAGR.
Current Price
$292.23
+1.41%GoodMoat Value
$938.27
221.1% undervaluedBio-Rad Laboratories Inc - Class A (BIO) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Bio-Rad Laboratories Inc - Class A's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $2.58B. Gross profit (TTM) is $1.34B. EBITDA is $1.04B. Earnings per share (EPS) is $27.85. The P/E ratio is 10.37. Market capitalization is $7.88B.
Free cash flow (FCF) is $374.70M. FCF growth rate is 0.69%. EPS growth CAGR is -13.05%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Bio-Rad Laboratories Inc - Class A's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
